Working… Menu
Trial record 1 of 1 for:    NCT01111188
Previous Study | Return to List | Next Study

Trial of PD 0332991 Plus Bortezomib in Patients With Relapsed Mantle Cell Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01111188
Recruitment Status : Terminated
First Posted : April 27, 2010
Last Update Posted : June 27, 2019
Millennium Pharmaceuticals, Inc.
Information provided by (Responsible Party):
Weill Medical College of Cornell University

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : February 26, 2013
Actual Study Completion Date : April 12, 2019